Derek Yuan - Profile and Investment Details

Investor Profile

Derek Yuan is a Venture Capital, Private Equity Firm based in Menlo Park, California, United States with a diverse investment portfolio that includes companies such as Zhangkong Tangniaobing, Aohua, Verdiva Bio, iECURE, inc., ImmuneOnco Biopharma, Cytek Biosciences, Baixing Pingan YaofangABclonal, Ansun BioPharma, Sciwind Biosciences, HiFiBiO, Nucleix, Aspen Neuroscience, Inc., Kali Therapeutics, Laviana Pharma, Edge Medical Robotics, Tempest Therapeutics, Cleveland Diagnostics, ProfoundBio, Zhenge Biotech, Just Medical, CANbridge Pharmaceuticals, Burning Rock Biotech, WinnTi Medical, CytoTronics, . Over time, Derek Yuan has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Derek Yuan is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Wellness, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Information Technology (IT), Manufacturing, Biotechnology, Medical Devices, Genomics, Innovation, Consulting, Mergers and Acquisitions, Health Diagnostics, Digital Health, Medical, Information Technology, B2B, Health Tech, Media and Entertainment, Personal Health, Pharmaceuticals, Acquisitions, Biometrics may find it worthwhile to explore potential connections with Derek Yuan, as their portfolio suggests a familiarity and interest in this area.

Understanding Derek Yuan’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.